Skip to content
Open access

Outcome evaluation of percutaneous coronary intervention vs medical therapy alone in patients with chronic coronary syndrome

Aug 2026 · Journal of Food and Drug Analysis · Vol 34, pp. 407 - 416 · 0 citations · 31 references
Medicine

TL;DR

Among CCS patients diagnosed non-invasively, the medication-only group demonstrated comparable all-cause mortality and MI rates, but a significantly lower risk of revascularization compared with the PCI group, while incurring only onethird of the healthcare costs.

Abstract

This study provides real-world evidence by comparing the long-term clinical outcomes of percutaneous coronary intervention (PCI) versus medical therapy alone in patients with chronic coronary syndrome (CCS) diagnosed non-invasively, given the lack of evidence in this population. This retrospective cohort study (2013–2018) utilized data from a medical center’s Cardiovascular Disease Databank, which was linked to national mortality records in Taiwan. Propensity score matching (PSM) and stabilized inverse probability of treatment weighting (IPTW) were applied to adjust for baseline differences between the PCI and medication-only groups. Major adverse cardiovascular events (MACE), including all-cause mortality, non-fatal myocardial infarction (MI), and revascularization, were compared between groups. After 1:4 propensity score matching, a total of 4369 patients were included (PCI, N = 1058; medication only, N = 3311). Adjusted Cox proportional hazards models showed that the PCI group had a higher hazard of MACE (aHR, 1.38 [95% CI, 1.22–1.56]), primarily driven by increased revascularization (aHR, 1.65 [95% CI, 1.39–1.95]), compared to the medication-only groups. No significant differences were observed in all-cause mortality (aHR, 1.13 [95% CI, 0.96–1.34]) or MI (aHR, 1.08 [95% CI, 0.77–1.52]). Furthermore, the mean total healthcare cost during the index year was US$3232 (SD = 9896) for the medication-only group, compared with US$10,931 (SD = 8781) for the PCI group. Among CCS patients diagnosed non-invasively, the medication-only group demonstrated comparable all-cause mortality and MI rates, but a significantly lower risk of revascularization compared with the PCI group, while incurring only onethird of the healthcare costs. Clinicians should carefully evaluate the benefits and risks of stent placement in CCS patients.

Read PDF

Similar papers

Open access Oct 2026

In-Hospital Outcomes According to Treatment Strategy in NSTEMI Patients Undergoing Coronary Angiography: No Index Revascularization, PCI, or CABG?

Patients managed with no index revascularization had a higher baseline risk profile and higher unadjusted in-hospital MACE and mortality, and the observed between-group differences should be interpreted as associations rather than causal effects of treatment strategy because of substantial confounding by indication.

K. Erdoğan, M. Sağlam, Serdal Baştuğ et al. · 0 citations
Open access Sep 2026

P2Y12 Inhibitor Selection and Ischemic Outcomes in Patients with Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention: A Real-World Registry Analysis

This study evaluated whether ticagrelor use is associated with improved ischemic outcomes compared with clopidogrel in Korean patients with acute coronary syndrome undergoing percutaneous coronary intervention. We analyzed patient-level data from 1,199 patients (614 clopidogrel, 585 ticagrelor) enrolled in two prospect...

Donghyeon Joo, Jeong Tae Byoun, Sungho Jo et al. · 0 citations
Sep 2026

Three-Year Outcomes Post Percutaneous Coronary Intervention for Left Main Coronary Artery Disease

PCI with drug-eluting stents for ULMCAD was safe and effective, with favorable long-term outcomes in patients who were unfit for surgery or refused surgery, and the provisional single-stent technique demonstrated better clinical outcomes than the double-stent approach.

K. N. O. Aljabry, Samir Taha Abeid, Y. A. Yasseen et al. · 0 citations
Open access Sep 2026

Long-Term Mortality with Contemporary Multivessel PCI Versus CABG in Patients with Diabetes and Multivessel Disease: A Population-Based Retrospective Cohort Study

Abstract Background: Coronary artery bypass grafting (CABG) is often preferred over percutaneous coronary intervention (PCI) in patients with diabetes mellitus (DM) and multivessel coronary artery disease (MVD), but whether it confers a long-term survival advantage remains unclear. Moreover, whether anatomic complexity...

X. Xiao, A. Savu, K. Bainey et al. · 0 citations
Aug 2026

Cangrelor in elderly patients undergoing percutaneous coronary intervention: findings from the ICARUS Registry.

Elderly patients were at higher risk of NACE, driven by an increased risk of both ischemic and bleeding events, the latter including access-site and nonaccess-site hemorrhages of both minor and major severity.

S. Benenati, F. Gragnano, Sebastiano Stratoti et al. · 1 citation

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.